scispace - formally typeset
L

Lawrence H. Muhlbaier

Researcher at Duke University

Publications -  121
Citations -  12032

Lawrence H. Muhlbaier is an academic researcher from Duke University. The author has contributed to research in topics: Coronary artery disease & Population. The author has an hindex of 53, co-authored 120 publications receiving 11747 citations. Previous affiliations of Lawrence H. Muhlbaier include Yale University & Durham University.

Papers
More filters
Journal ArticleDOI

Discordance of Databases Designed for Claims Payment versus Clinical Information Systems: Implications for Outcomes Research

TL;DR: This study examined the suitability of billing data compared with clinical data (prospectively collected for cardiology research and patient care) for use in clinical outcomes research and found that billing data is limited by the unstructured way in which they are collected.
Journal ArticleDOI

Outcomes of cardiac surgery in patients age ≥80 years: results from the National Cardiovascular Network

TL;DR: Risks for octogenarians undergoing cardiac surgery are less than previously reported, especially for CABG only or CABg/AVR, and mortality approaches that seen in younger patients.
Journal ArticleDOI

Laparoscopic Versus Open Appendectomy: Outcomes Comparison Based on a Large Administrative Database

TL;DR: Laparoscopic appendectomy has significant advantages over open appendectomy with respect to length of hospital stay, rate of routine discharge, and postoperative in-hospital morbidity.
Journal ArticleDOI

Value of the History and Physical in Identifying Patients at Increased Risk for Coronary Artery Disease

TL;DR: Whether a physician's office evaluation of a patient with nonacute chest pain could identify high-and low-risk patients and to evaluate the potential importance of this information in the delivery of cost-effective quality care is evaluated.
Journal ArticleDOI

Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease

TL;DR: Use of evidence-based therapies for CAD has improved but remains suboptimal, and considerable attention must also be focused on understanding and improving long-term adherence.